Circulating tumor HPV DNA for surveillance of HPV-positive oropharyngeal squamous cell carcinoma: A narrative review
Importance Human papillomavirus (HPV)–positive oropharyngeal squamous cell carcinoma
has an overall favorable prognosis, yet a subset of patients will experience devastating …
has an overall favorable prognosis, yet a subset of patients will experience devastating …
Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline
SA Koyfman, N Ismaila, D Crook, A D'Cruz… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE The aim of the current work is to provide evidence-based recommendations to
practicing physicians and others on the management of the neck in patients with squamous …
practicing physicians and others on the management of the neck in patients with squamous …
[HTML][HTML] Advances in imaging for HPV-related oropharyngeal cancer: applications to radiation oncology
TC Salzillo, N Taku, KA Wahid, BA McDonald… - Seminars in radiation …, 2021 - Elsevier
While there has been an overall decline of tobacco and alcohol-related head and neck
cancer in recent decades, there has been an increased incidence of HPV-associated …
cancer in recent decades, there has been an increased incidence of HPV-associated …
[HTML][HTML] Magnetic resonance-based response assessment and dose adaptation in human papilloma virus positive tumors of the oropharynx treated with radiotherapy …
Background Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …
Cost‐Effectiveness Analysis of PET‐CT Surveillance After Treatment of Human Papillomavirus‐Positive Oropharyngeal Cancer
ME Lin, CX Castellanos, JR Acevedo… - … –Head and Neck …, 2024 - Wiley Online Library
Objective To determine the cost‐effectiveness of surveillance imaging with PET/CT scan
among patients with human papillomavirus‐positive oropharyngeal squamous cell …
among patients with human papillomavirus‐positive oropharyngeal squamous cell …
Radiation therapy alone for human papillomavirus-related squamous cell carcinoma of the oropharynx: a single-arm, phase 2 study
N Takemoto, Y Seo, S Nakahara, Y Yoshioka… - International Journal of …, 2021 - Elsevier
Purpose Human papillomavirus (HPV)-related squamous cell carcinoma of the oropharynx
(OPSCC) is extremely radiosensitive. Radiation therapy plus high-dose cisplatin remains the …
(OPSCC) is extremely radiosensitive. Radiation therapy plus high-dose cisplatin remains the …
Patient burden with current surveillance paradigm and factors associated with interest in altered surveillance for early stage HPV-related oropharyngeal cancer
LA Gharzai, N Burger, P Li, EM Jaworski… - The …, 2021 - academic.oup.com
Introduction Optimal surveillance paradigms for survivors of early stage human
papillomavirus (HPV)-related oropharyngeal cancer are not well defined. This study aimed …
papillomavirus (HPV)-related oropharyngeal cancer are not well defined. This study aimed …
Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: a partially observed Markov decision process model
Background A possible surveillance model for patients with head and neck cancer (HNC)
who received definitive radiotherapy was created using a partially observed Markov …
who received definitive radiotherapy was created using a partially observed Markov …
Accuracy of response assessment positron emission tomography-computed tomography following definitive radiotherapy without chemotherapy for head and neck …
Aim There are few data to inform on the use of response assessment 2-[fluorine-18]-fluoro-2-
deoxy-d-glucose (FDG) positron emission tomography-computed tomography (PET-CT) …
deoxy-d-glucose (FDG) positron emission tomography-computed tomography (PET-CT) …
Follow‐up for human papillomavirus‐related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient‐reported outcome …
DM Edwards, LA Gharzai, W Wang, C Mayo… - Head & …, 2024 - Wiley Online Library
Background Post‐treatment surveillance recommendations for oropharyngeal cancer do not
vary with p16 status despite the differences in outcomes. The optimal algorithm …
vary with p16 status despite the differences in outcomes. The optimal algorithm …